These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 15364711)
21. Factors predictive of long-term visual outcomes of Group D eyes treated with chemoreduction and low-dose IMRT salvage: the Children's Hospital Los Angeles experience. Berry JL; Jubran R; Wong K; Lee TC; Murphree AL; Kim JW Br J Ophthalmol; 2014 Aug; 98(8):1061-5. PubMed ID: 24671926 [TBL] [Abstract][Full Text] [Related]
22. Vision-Targeted Health-Related Quality of Life in Adult Survivors of Retinoblastoma. Friedman DN; Chou JF; Francis JH; Sklar CA; Li Y; McCabe M; Robison LL; Kleinerman RA; Oeffinger KC; Abramson DH; Dunkel IJ; Ford JS JAMA Ophthalmol; 2018 Jun; 136(6):637-641. PubMed ID: 29710339 [TBL] [Abstract][Full Text] [Related]
23. Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in Austria. Sovinz P; Urban C; Lackner H; Benesch M; Langmann G Wien Klin Wochenschr; 2006 Feb; 118(1-2):22-30. PubMed ID: 16489522 [TBL] [Abstract][Full Text] [Related]
24. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743 [TBL] [Abstract][Full Text] [Related]
26. Current concepts for diagnosis and treatment of retinoblastoma in Germany: aiming for safe tumor control and vision preservation. Temming P; Lohmann D; Bornfeld N; Sauerwein W; Goericke SL; Eggert A Klin Padiatr; 2012 Oct; 224(6):339-47. PubMed ID: 23143761 [TBL] [Abstract][Full Text] [Related]
27. Chemoreduction in the management of retinoblastoma. Shields JA; Shields CL; Meadows AT Am J Ophthalmol; 2005 Sep; 140(3):505-6. PubMed ID: 16139001 [No Abstract] [Full Text] [Related]
29. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Abramson DH; Frank CM Ophthalmology; 1998 Apr; 105(4):573-9; discussion 579-80. PubMed ID: 9544627 [TBL] [Abstract][Full Text] [Related]
30. Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Friedman DN; Sklar CA; Oeffinger KC; Kernan NA; Khakoo Y; Marr BP; Wolden SL; Abramson DH; Dunkel IJ Pediatr Blood Cancer; 2013 Apr; 60(4):694-9. PubMed ID: 22911631 [TBL] [Abstract][Full Text] [Related]
32. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557 [TBL] [Abstract][Full Text] [Related]
33. Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision. Tsimpida M; Thompson DA; Liasis A; Smith V; Kingston JE; Sagoo MS; Reddy MA Br J Ophthalmol; 2013 Nov; 97(11):1464-70. PubMed ID: 24037611 [TBL] [Abstract][Full Text] [Related]
34. Clinical profile, management, and outcome of retinoblastoma in singapore. Lim FP; Soh SY; Iyer JV; Tan AM; Swati H; Quah BL J Pediatr Ophthalmol Strabismus; 2013; 50(2):106-12. PubMed ID: 23244241 [TBL] [Abstract][Full Text] [Related]
35. Focal therapy in the management of retinoblastoma: when to start and when to stop. Hamel P; Heon E; Gallie BL; Budning AS J AAPOS; 2000 Dec; 4(6):334-7. PubMed ID: 11124666 [TBL] [Abstract][Full Text] [Related]
36. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557 [TBL] [Abstract][Full Text] [Related]
37. A prospective study of children treated for retinoblastoma: cognitive and visual outcomes in relation to treatment. Ek U; Seregard S; Jacobson L; Oskar K; Af Trampe E; Kock E Acta Ophthalmol Scand; 2002 Jun; 80(3):294-9. PubMed ID: 12059869 [TBL] [Abstract][Full Text] [Related]
38. Clinical manifestations and treatment of retinoblastoma in Kobe children's hospital for 16 years. Okimoto S; Nomura K J Pediatr Ophthalmol Strabismus; 2014 Jul; 51(4):222-9. PubMed ID: 24844394 [TBL] [Abstract][Full Text] [Related]
39. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation. Chan MP; Hungerford JL; Kingston JE; Plowman PN Br J Ophthalmol; 2009 Jul; 93(7):891-4. PubMed ID: 19329423 [TBL] [Abstract][Full Text] [Related]